hitters

Progress with a cancer treatment and brimming excitement about the prospect of a coronavirus vaccine breakthrough proved to be just the pill for traders yesterday. Pharmaceutical heavyweight Glaxosmithkline was on the up after an independent panel in the US encouraged regulators to approve the company’s experimental therapy for a common type of blood cancer. All … Read more